Patients with SLE and chronic inflammatory demyelinating polyneuropathy, for example, were shown to express lower levels of FcγRIIb on mature B cells and failed to upregulate FcγRIIb expression on memory B cells (Mackay et al., 2006; Tackenberg et al., 2009). Here, FCGR2B is linked to systemic lupus erythematosus.